Tendinitis is an inflammation of the thick cords, ligament, which attaches muscle to bone, also known as tendonitis. An inflammation or swelling happens due to sudden damage to the ligament, rheumatoid joint inflammation, redundant development of diabetes, gout, Reiter’s disorder or lupus. Tendinitis is one of the basic sport injuries in the players, particularly golf, tennis, and others. Different pharmacological & non-pharmacological medications are available for the treatment of tendinitis. However, surgery is the last solution for tendinitis, and is only recommended in case of severe injure to the tendon which cannot be treated with pharmacological treatment options.
According to study, “Tendinitis Treatment Market Information: By Type (Achilles Tendinitis, Supraspinatus Tendinitis, Tennis or Golfers Elbow, De Quervains Tenosynovitis), By Treatment (Diagnosis, Therapy, Shock Wave Therapy or Surgery, Medical Devices, Devices), By End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes) – Americas & Europe Forecast till 2023” the key companies operating in the Americas & Europe tendinitis treatment market are Abbott Laboratories, Merck & Co. Inc., Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline plc., Pfizer Inc., Bayer, Teva Pharmaceutical Industries, AstraZeneca.
Based on type, Americas & Europe tendinitis treatment market is segmented into Achilles Tendinitis, Tennis or Golfer’s Elbow, Supraspinatus Tendinitis and De Quervain’s Tenosynovitis. Based on treatment, market is segmented into diagnosis, shock wave therapy or surgery, therapy and medical devices and medical devices (mechanical band, pre-cut strips, support tape and continuous rolls). Diagnosis treatment is further sub-segmented into imaging tests (Magnetic Resonance Imaging (MRI) scans and ultrasound), physical exam, and others. Therapy is further sub-segmented into pharmacological and non-pharmacological therapy. Pharmacological therapy includes corticosteroids injections, OTC drugs or pain relievers and platelet-rich plasma (PRP) while non-pharmacological therapy includes rest therapy, occupational therapy, heat & cold therapy and physical therapy. Based on problem, market is segmented into golfer’s elbow, pitcher’s shoulder, jumper’s knee, swimmer’s shoulder, tennis elbow, and others. In addition based on end-user, market is segmented into hospitals & clinics, academic institutes and medical research centers.
The Americas & Europe tendinitis treatment market is driven by increase in geriatric population, followed by rise in prevalence of sports injuries, rapid adoption of new treatments, growth in healthcare infrastructure, innovative product development, and increase in prevalence of patients suffering from diabetes & rheumatoid. However, side effects of the treatment, lack of physical activity and change in lifestyle may impact the market.
Based on geography, American region is the major market for tendinitis treatment owing to rise in prevalence of sport injuries & disease such as arthritis and increase in demand for new treatment options for tendinitis in the region. European region is expected to witness higher growth rate due to increase in availability of funds for research and development (R&D) activities in medical devices and rise in prevalence of diabetes & rheumatoid arthritis over the forecast period. The market is expected to reach the approx value of US $13,099.0 million by 2023 growing at a CAGR of 7.2% during the forecast period.
For more information, click on the link below:
Ankur Gupta, Head Marketing & Communications